Bio-Rad Laboratories (NYSE:BIO.B) Hits New 1-Year High – Time to Buy?

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) shares hit a new 52-week high on Friday . The stock traded as high as $357.05 and last traded at $357.05, with a volume of 332 shares trading hands. The stock had previously closed at $348.95.

Bio-Rad Laboratories Stock Up 2.3 %

The firm has a market cap of $10.00 billion, a P/E ratio of -13.06 and a beta of 0.72. The firm’s fifty day moving average is $334.34 and its 200 day moving average is $326.67. The company has a debt-to-equity ratio of 0.16, a quick ratio of 4.52 and a current ratio of 6.14.

Bio-Rad Laboratories (NYSE:BIO.B) last released its earnings results on Wednesday, October 30th. The company reported $2.01 earnings per share for the quarter. Bio-Rad Laboratories had a positive return on equity of 3.74% and a negative net margin of 30.18%. The firm had revenue of $649.73 million during the quarter.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.